Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Busby

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|September 20, 2013
Linaclotide pharmacodynamicsRobert W Busby, George Zhang
Digestive Diseases and Sciences|March 22, 2014
Clarification of linaclotide pharmacology presented in a recent clinical study of plecanatideRobert W Busby, Stephan Ortiz
Pharmacology Research & Perspectives|December 16, 2014
Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeysAli R Banijamali, James D Wakefield, Ara H Mermerian, et al.
Pharmacology Research & Perspectives|December 17, 2021
Metopimazine is primarily metabolized by a liver amidase in humansRobert W Busby, Xiaokun Cai, Sihyung Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2012
Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipationRobert W Busby, Marco M Kessler, Wilmin P Bartolini, et al.
Life Sciences|March 24, 2010
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tractAlexander P Bryant, Robert W Busby, Wilmin P Bartolini, et al.
European Journal of Pharmacology|September 25, 2010
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transitRobert W Busby, Alexander P Bryant, Wilmin P Bartolini, et al.
Journal of Medicinal Chemistry|February 6, 2026
Carboxylic Acid Bioisosteres of Creatine as Novel and Selective Substrate Competitive Inhibitors of the Creatine Transporter SLC6A8Eduardo J Martinez, Darren H Wong, Amish J Patel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
P & T : a Peer-Reviewed Journal for Formulary Management|September 20, 2013
Linaclotide pharmacodynamicsRobert W Busby, George Zhang
Digestive Diseases and Sciences|March 22, 2014
Clarification of linaclotide pharmacology presented in a recent clinical study of plecanatideRobert W Busby, Stephan Ortiz
Pharmacology Research & Perspectives|December 16, 2014
Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeysAli R Banijamali, James D Wakefield, Ara H Mermerian, et al.
Pharmacology Research & Perspectives|December 17, 2021
Metopimazine is primarily metabolized by a liver amidase in humansRobert W Busby, Xiaokun Cai, Sihyung Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2012
Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipationRobert W Busby, Marco M Kessler, Wilmin P Bartolini, et al.
Life Sciences|March 24, 2010
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tractAlexander P Bryant, Robert W Busby, Wilmin P Bartolini, et al.
European Journal of Pharmacology|September 25, 2010
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transitRobert W Busby, Alexander P Bryant, Wilmin P Bartolini, et al.
Journal of Medicinal Chemistry|February 6, 2026
Carboxylic Acid Bioisosteres of Creatine as Novel and Selective Substrate Competitive Inhibitors of the Creatine Transporter SLC6A8Eduardo J Martinez, Darren H Wong, Amish J Patel, et al.
Pageof 1